Related Experiment Video
Updated: Apr 3, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Congenital and acquired bleeding disorders in infancy
Sally Elizabeth Campbell1, Paula H B Bolton-Maggs2
1Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne 3052 Australia; Clinical Haematology - Royal Children's Hospital, University of Melbourne, Melbourne Australia.
Diagnosing infant bleeding disorders requires understanding developmental hemostasis and neonatal platelets. A systematic approach aids clinicians in identifying and treating these conditions effectively.
Area of Science:
- Pediatric Hematology
- Neonatal Hemostasis
Background:
- Infant bleeding disorders necessitate understanding developmental hemostasis.
- Neonatal hemostasis differs significantly from adult hemostasis, impacting laboratory diagnostics.
Purpose of the Study:
- To review the presentation and diagnosis of congenital and acquired bleeding disorders in neonates.
- To highlight the importance of a systematic diagnostic approach in clinical practice.
Main Methods:
- Literature review focusing on congenital and acquired bleeding disorders in infants.
- Discussion of diagnostic pathways tailored to the clinical setting.
- Inclusion of platelet disorders and current research areas.
Main Results:
- Bleeding disorders in neonates stem from diverse causes requiring specific diagnostic strategies.
- Understanding developmental hemostasis is crucial for accurate laboratory interpretation.
- Platelet disorders represent a significant category within neonatal bleeding conditions.
Conclusions:
- A systematic approach is vital for diagnosing and managing neonatal bleeding disorders.
- Ongoing research into neonatal platelet function and coagulation factor interactions is critical.
- Further investigation into transfusion thresholds and homeostatic mechanisms is warranted.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Esophageal Varices-I: Introduction

